文献速递骨质疏松与钙磷/甲状旁腺

血清甲状旁腺激素与冠心病风险:孟德尔随机化探索因果性

Serum Parathyroid Hormone and Risk of Coronary Artery Disease: Exploring Causality Using Mendelian Randomization.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

采用孟德尔随机化设计,以5个与血清甲状旁腺激素(S-PTH)强相关的单核苷酸多态性为工具变量,基于184305名个体(60801例冠心病)的遗传学汇总数据,评估遗传预测的S-PTH升高与冠心病风险的因果关联。结果显示,遗传预测的S-PTH每升高1个标准差,冠心病OR为1.01(95%CI 0.93-1.09;P=0.88),心肌梗死OR为1.02(95%CI 0.94-1.10;P=0.64),提示遗传决定的S-PTH升高不构成冠心病的独立危险因素。

要点

  • 遗传预测的S-PTH升高与冠心病整体无显著关联(OR 1.01,95%CI 0.93-1.09)。
  • 遗传预测的S-PTH升高与心肌梗死也无显著关联(OR 1.02,95%CI 0.94-1.10)。
  • 多项敏感性分析均支持S-PTH升高不是冠心病的独立因果危险因素。

核心结论

  • 遗传决定的血清甲状旁腺激素升高不构成冠心病的独立危险因素。

研究设计与样本

  • 孟德尔随机化研究,使用5个与S-PTH强相关的单核苷酸多态性作为工具变量。
  • 冠心病汇总数据来自遗传学联盟,共184305名个体(60801例冠心病,123504例非冠心病)。

主要发现

  • 遗传预测的S-PTH每升高1个标准差,冠心病OR为1.01(95%CI 0.93-1.09;P=0.88)。
  • 遗传预测的S-PTH每升高1个标准差,心肌梗死OR为1.02(95%CI 0.94-1.10;P=0.64)。
  • 多项敏感性分析未改变无显著关联的结果。

临床怎么用

  • 不支持将遗传性S-PTH升高作为冠心病的独立筛查或干预靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Elevated circulating parathyroid hormone concentrations have been associated with increased risk of cardiovascular disease in observational studies, but whether the association is causal is unknown. OBJECTIVE: We used the Mendelian randomization design to test whether genetically increased serum parathyroid hormone (S-PTH) concentrations are associated with coronary artery disease (CAD). DESIGN, SETTING, AND PARTICIPANTS: Five single-nucleotide polymorphisms robustly associated with S-PTH concentrations were used as instrumental variables to estimate the association of genetically higher S-PTH concentrations with CAD. Summary statistics data for CAD were obtained from a genetic consortium with data from 184,305 individuals (60,801 CAD cases and 123,504 noncases). MAIN OUTCOME MEASURE: OR of CAD per genetically predicted one SD increase of S-PTH concentrations. RESULTS: Genetically higher S-PTH concentration was not associated with CAD as a whole or myocardial infarction specifically (∼70% of total cases). The ORs per genetically predicted one SD increase in S-PTH concentration were 1.01 (95% CI: 0.93 to 1.09; P = 0.88) for CAD and 1.02 (95% CI: 0.94 to 1.10; P = 0.64) for myocardial infarction. The lack of association remained in various sensitivity analyses. CONCLUSION: Genetic predisposition to higher S-PTH concentrations does not appear to be an independent risk factor for CAD.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Melhus H, Michaëlsson K, Larsson SC, et al. Serum Parathyroid Hormone and Risk of Coronary Artery Disease: Exploring Causality Using Mendelian Randomization. J Clin Endocrinol Metab. 2019. PMID: 31310319. doi:10.1210/jc.2019-01063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。